Literature DB >> 22924496

Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.

Young Ho Lee1, Gwan Gyu Song.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the tumor necrosis factor-alpha-inducible protein 3 (TNFAIP3) polymorphisms confer susceptibility to systemic lupus erythematosus (SLE) in ethnically different populations.
METHODS: The authors conducted meta-analyses on associations between the TNFAIP3 polymorphisms and SLE susceptibility, using fixed and random effects models.
RESULTS: A total of eight comparative studies were included in this meta-analysis, which included four Asian, three European, and one African American population. Meta-analysis revealed that an association was found between the minor allele of rs2230926 and SLE in all subjects (odds ratio [OR] 1.848, 95% confidence interval [CI] 1.547-2.208, p<1.0×10(-9)). After stratification by ethnicity, the minor allele of rs2230926 was found to be significantly associated with SLE in Asians and Europeans (OR 1.821, 95% CI 1.495-2.219, p<1.0×10(-9); OR 2.251, 95% CI 1.830-2.768, p<1.0×10(-9)). In addition, a significant association was found between the minor allele of the rs5029939 polymorphism and the risk of developing SLE in all study subjects and Europeans (OR 1.804, 95% CI 1.255-2.592, p=0.001; OR 2.145, 95% CI 1.731-2.658, p<1.0×10(-9)). Furthermore, an association was found between the minor allele of rs3757173 and SLE in all study subjects (OR 1.540, 95% CI 1.017-2.331, p=0.041). However, no association was found between SLE susceptibility and rs6922466 (OR 0.953, 95% CI 0.812-1.120, p=0.561).
CONCLUSIONS: This meta-analysis confirms that the TNFAIP3 polymorphisms are associated with SLE susceptibility in different ethnic groups, namely in Asians and Europeans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924496     DOI: 10.1089/gtmb.2012.0096

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  5 in total

1.  Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population.

Authors:  Pingping Zhang; Na Li; Qianqian Zhu; Fang Li; Cuiling Yang; Xiaoyan Zeng; Yi Lv; Zhihua Zhou; Qunying Han; Zhengwen Liu
Journal:  Virol J       Date:  2015-02-28       Impact factor: 4.099

2.  Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Authors:  Zala Jevnikar; Rebecca Riise; Lina Odqvist; Lisa Öberg; Magdalena Rhedin; Dag Leonard; Linda Yrlid; Sonya Jackson; Johan Mattsson; Sambit Nanda; Philip Cohen; Axel Knebel; Simon Arthur; Kristofer Thörn; Elisabet Svenungsson; Andreas Jönsen; Iva Gunnarsson; Karolina Tandre; Andrei Alexsson; Alf Kastbom; Solbritt Rantapää-Dahlqvist; Maija-Leena Eloranta; Ann-Christine Syvänen; Anders Bengtsson; Patrik Johansson; Johanna K Sandling; Christopher Sjöwall; Lars Rönnblom; Barry Collins; Outi Vaarala
Journal:  Ann Rheum Dis       Date:  2019-07-12       Impact factor: 19.103

3.  Association of <em>TNFAIP3</em> gene polymorphism (<em>rs5029939</em>) with susceptibility and clinical phenotype of systemic lupus erythematosus.

Authors:  Hala Gaballah; Reham Abd-Elkhalek; Ola Hussein; Shimaa Abd El-Wahab
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.472

4.  The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.

Authors:  George Couch; James E Redman; Lorenz Wernisch; Richard Newton; Shalini Malhotra; Sanford M Dawsey; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-12

5.  An Autoimmune Disease-Associated Risk Variant in the TNFAIP3 Gene Plays a Protective Role in Brucellosis That Is Mediated by the NF-κB Signaling Pathway.

Authors:  Lixin Lou; Wanguo Bao; Xianjun Liu; Hongxiao Song; Yang Wang; Kaiyu Zhang; Wenjing Gao; Haijun Li; Zhengkun Tu; Shaofeng Wang
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.